Two medical companies say they've reached an agreement with the UK government for up to 60 million doses of a possible coronavirus vaccine

The deal is with Sanofi and Brentford-based GlaxoSmithKline, who announced they were teaming-up back in April.

The first clinical trials are expected in September and they’re hoping to get approval next year.

This is the fourth agreement of this type ministers have struck with firms.